Biodesix(美国)

Biodesix

美国Biodesixwww.biodesix.com美国Biodesix成立于2005年,将分子诊断应用于个性化医疗.Biodesixwasfoundedin2005toapplytheprinciplesofcomplexdataanalysisandmassspectrometry(MS)tothediscoveryanddevelopmentofimprovedmultivariatetes tsthatgivephysiciansbetterinformationtounderstandthepatientandtheirdisease.Understandingtheclinicallymeaningfulinformationcontainedwithineachpatient’smolecularprofilemayimprovediagnosisandtherapeuticinterventionandleadtobetteroutcomes.WehavedemonstratedleadershipinpersonalizingmedicinebyintroducingVeriStrat®,thefirstserumproteomictestforadvancednon-smallcelllungcancerpatientsthathelpsphysiciansdetermineifapatientshouldreceivetreatmentwitherlotinib(Tarceva®),anepidermalgrowthfactorinhibitor.ToenablethereliableuseofMSforanalysisofpatientsamples,BiodesixscientistsdevelopedProTS®,aproprietarytechnologyplatformthatharnes